Sponsor:
Mayo Clinic
Code:
NCT06751069
Conditions
Lung Fibrosis
Lung Interstitial Disease
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Home-based Pulmonary Rehab
Brief summary:
Conditions
Lung Fibrosis
Lung Interstitial Disease
Study ID
NCT06751069
Start date
Mar 3, 2025
Status verified date
Mar, 2026
Completion date
Sep 30, 2030
Anticipated
Primary completion date
Jul 1, 2030
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
460 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Home-based Pulmonary Rehabilitation with Health Coaching Group
no intervention: Non-use Waitlist Control Observation Group
Interventions
Home-based Pulmonary Rehab
Primary outcome measure
Central contacts
Locations
Mayo Clinic in Arizona
Recruiting
Scottsdale, Arizona, United States, 85259
Principal Investigator:
Ana Zamora Martinez, MD
Mayo Clinic in Florida
Recruiting
Jacksonville, Florida, United States, 32224
Principal Investigator:
Hassan Z Baig, MD
University of Minnesota
Recruiting
Minneapolis, Minnesota, United States, 55455
Contacts
Principal Investigator:
Hyun Kim, MD
Mayo Clinic in Rochester
Recruiting
Rochester, Minnesota, United States, 55905
Contacts
Principal Investigator:
Teng Moua, MD
Sponsor
Mayo Clinic
Last update posted
Mar 20, 2026
Last verified
Mar, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Mayo Clinic on 2026-03-20.